Our study reveals a previously unanticipated extent of PLN contribution to cardiac disease worldwide, highlighting the need for heightened clinical awareness on the value of PLN genetic testing, as well as the interpretation and clinical integration of these results towards enhanced diagnosis, prognosis and clinical management of cardiomyopathy patients and their family members. Here, PLN is linked to cardiomyopathy.